We and others have extensively investigated and reported the underlying apoptotic mechanisms of IL-24 protein treatment and Ad.IL-24 infection in preclinical studies in several cancer cells, including melanoma, glioblastoma, breast, prostate, lung, colon, liver, and cervical cancer cells [3,4,5,6,10,36,37,38]. This evidence concerns the gene IL24 and cervical carcinoma.